Omnicom Shop to Open in London

Omnicom Group healthcare shop Cline, Davis & Mann is opening an office on Dec. 1 in London in an effort to better compete for global pharmaceutical accounts.

The New York shop is sending to London three of the 10 staffers currently working on Amgen’s Ara nesp, a kidney-related anemia treatment. (CDM won the Thousand Oaks, Calif.-based biotech giant’s estimated $10 million U.S. Aranesp business in March and the estimated $5 million European portion in August.) Lila Shah, vp, account group supervisor, will head the new office.

CDM has had its share of new-business frustration in 2002, most recently losing the global review for Novartis’ $100 million Zelnorm business to Deutsch. CDM was shut out of the $100 million global review for TAP Pharmaceutical’s Prevacid, won by Omnicom’s Merkley Newman Harty & Partners. And it was unable to get into the $80 million global re view for Pharmacia’s and Pfizer’s Cel ebrex. Besides Amgen, CDM has won only a handful of smaller accounts this year and no other global business.

“We currently have eight global clients, and we’re going to offer CDM Europe to them, and yes, this will help us move up to the next level in terms of getting into more global reviews,” said CDM president and CEO Ed Wise.

CDM will have just as much competition on the continent. Shops such as Grey Healthcare and Havas’ Euro RSCG Healthcare have been preparing to expand their European presence, sources said.

CDM claims billings of $470 million and has about 350 staffers. Clients include Pfizer and GlaxoSmithKline.